Application of dimethyl carnosol in preparation of medicine for treating cachexia disease

A technology of dimethyl carnosol and cachexia, applied in the application field of medicine, can solve problems such as failure, shortened survival period, and no breakthrough progress of new drugs, so as to relieve muscle atrophy, relieve lipolysis, and relieve weight and the effect of reduced food intake

Active Publication Date: 2021-08-13
EAST CHINA NORMAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The most promising new drugs in the clinical research stage in the near future are Anamorelin (anamorelin, a ghrelin receptor agonist) and Enobosarm (a selective AR agonist), but the current phase III of these two drugs Clinical studies all ended in failure
[0007] In conclusion, since tumor cachexia is the main complication of various malignant tumor patients, it not only weakens the effect of chemotherapy and radiotherapy, shortens the survival period, but also seriously affects the quality of life of patients.
Although the importance and necessity of tumor cachexia treatment has gained a consensus, due to its complex pathogenesis, the current research is only the tip of the iceberg, and there is no breakthrough in the treatment of tumor cachexia and the development of new drugs. Currently, no drug has been approved as a specific drug for tumor cachexia, so the research and development of new drugs for tumor cachexia need to be deepened urgently

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of dimethyl carnosol in preparation of medicine for treating cachexia disease
  • Application of dimethyl carnosol in preparation of medicine for treating cachexia disease
  • Application of dimethyl carnosol in preparation of medicine for treating cachexia disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0163] Example 1 Synthesis of Dimethylcarnosol Add 300mg carnosol, 250mg potassium carbonate and 20mL anhydrous acetone into a 50mL reaction flask, add 1mL methyl iodide under nitrogen protection, and react in the dark for 48 hours at room temperature. The liquid turned from colorless to brown, and the solid was removed by suction filtration. The filtrate was concentrated to dryness and separated by column chromatography to obtain 70 mg of white solid, with a yield of 21.5%. LC-MS (ESI) m / z C 22 h 31 o 4 [M+H] + calcd for 359.2, found 359.4.

Embodiment 2

[0164] The synthesis of embodiment 2 bismethyl deuterated carnosol

[0165] Add 750mg of carnosol, 600mg of potassium carbonate and 50mL of anhydrous acetone to a 100mL reaction bottle, add 3mL of deuterated methyl iodide under nitrogen protection, and react in the dark for 48 hours at room temperature. The reaction solution turns from colorless to brown, and is filtered by suction The solid was removed, the filtrate was concentrated to dryness and separated by column chromatography to obtain 135 mg of white solid with a yield of 16.3%. LC-MS (ESI) m / z C 22 h 25 D. 6 o 4 [M+H]+ calcd for 364.3, found 365.5.

Embodiment 3

[0166] Example 3 Carnosol, dimethyl carnosol and dimethyl deuterated carnosol on mouse myoblast (C2C12) viability experiment

[0167] The survival rate of C2C12 cells was detected by MTT assay. The detection principle is that succinate dehydrogenase in the mitochondria of living cells can reduce exogenous MTT to water-insoluble blue-purple crystal formazan (Formazan) and deposit in the cells, while dead cells do not have this function. Triple solution (10% SDS + 5% isobutanol + 0.01% concentrated hydrochloric acid, aqueous solution) can dissolve formazan in cells, and measure its light absorption value at a wavelength of 570nm with an enzyme-linked immunosorbent assay, which can indirectly reflect the number of living cells . Within a certain cell number range, the amount of MTT crystal formation is proportional to the cell number.

[0168] The effect of the drug on the viability of mouse myoblasts (C2C12) can be evaluated by the above method. The specific method is as foll...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention innovatively provides the application of the carnosol compound in preparation of medicine for treating cachexia for the first time. The carnosol compound comprises a carnosol compound shown as a formula X, dimethyl deuterated carnosol shown as a formula 1, dimethyl carnosol shown as a formula 2 and the like. The invention further provides a novel compound, namely the dimethyl deuterated carnosol shown in the formula 1 and a preparation method thereof. The invention also provides a pharmaceutical composition for treating cachexia diseases. The invention further provides application of the compound in preparation of the medicine for treating the tumor cachexia, including muscle atrophy caused by tumor tissue, lipopenia caused by tumor tissue, appetite reduction caused by tumor tissue, inflammatory response caused by tumor tissue and tumor cachexia caused by digestive tract related cancer, liver cancer, lung cancer and colon cancer. The invention also provides application of the compound in preparation of medicines or inhibitors for treating or inhibiting muscle atrophy, medicines or inhibitors for inhibiting or relieving fat cell lipolysis, and medicines or inhibitors for inhibiting or relieving weight loss or reduction. The dimethyl carnosol provided by the invention has a wide application prospect.

Description

technical field [0001] The present invention relates to the field of drug synthesis, in particular to the application of a formula (2) dimethyl carnosol in the preparation of drugs for treating cachexia. Background technique [0002] Cachexia is a progressive wasting syndrome accompanied by systemic failure such as weight loss, anemia, and mental decline. It is mostly caused by cancer and other serious chronic diseases (such as chronic pulmonary obstruction, chronic heart failure, AIDS, etc.) cachexia is called tumor cachexia. Cancer cachexia is the main complication of various malignant tumor patients and the main cause of death of many cancer patients. The prevention and treatment of tumor cachexia has become an important part of the multidisciplinary treatment of malignant tumors and is receiving more and more attention. Tumor cachexia is a wasting syndrome characterized by systemic metabolic disorders, progressive muscle and fat consumption, weight loss, and progressiv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/366A61P35/00A61P13/12A61P11/00A61P9/04A61P21/00A61P1/14A61P29/00A61P3/00C07D493/10
CPCA61K31/366A61P35/00A61P13/12A61P11/00A61P9/04A61P21/00A61P1/14A61P29/00A61P3/00C07D493/10
Inventor 章雄文李奕伟潘俊芳刘璇
Owner EAST CHINA NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap